Primary Site >> Colorectal Cancer
Gene >> CYP2A6
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
|
Ref: Expression of CYP2A6 in tumor cells augments cellular sensitivity to tegafur. PMID: 11376561 |
Ref: CYP2A6 activity determined by caffeine phenotyping: association with colorectal cancer risk. PMID: 11927498 Ref: Analysis of total meat intake and exposure to individual heterocyclic amines in a case-control study of colorectal cancer: contribution of metabolic variation to risk. PMID: 12351157 Ref: A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. PMID: 12419832 Ref: Novel markers of susceptibility to carcinogens in diet: associations with colorectal cancer. PMID: 12505289 |
Ref: A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer. PMID: 16006997 |
Ref: Overexpression of CYP2A6 in human colorectal tumors. PMID: 17683511 |
Ref: Associations of various gene polymorphisms with toxicity in colorectal cancer patients receiving oral uracil and tegafur plus leucovorin: a prospective study. PMID: 20647221 |
Ref: [Validation of genetic polymorphisms associated to the toxicity of chemotherapy in colorectal cancer patients]. PMID: 25137161 Ref: In-silico structural, virtual screening and docking studies of Human Cytochrome P450 2A7 protein. PMID: 25519152 |
Ref: In Silico Structural, Virtual Screening and Docking Studies of Human Cytochrome P450 2A7 Protein. PMID: 26239541 |
Ref: A phase II study of preoperative chemoradiation with tegafur-uracil plus leucovorin for locally advanced rectal cancer with pharmacogenetic analysis. PMID: 28347333 |
Ref: Drug resistance induces the upregulation of H2S-producing enzymes in HCT116 colon cancer cells. PMID: 29061341 |